We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+14.1%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$19.8B
AUM Growth
+$2.97B
(+18%)
Cap. Flow
+$774M
Cap. Flow
% of AUM
3.9%
Top 10 Holdings %
Top 10 Hldgs %
22.92%
Holding
1,110
New
158
Increased
343
Reduced
427
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
lululemon athletica
LULU
|
+$160M |
| 2 |
Old Dominion Freight Line
ODFL
|
+$113M |
| 3 |
Intel
INTC
|
+$107M |
| 4 |
Mastercard
MA
|
+$104M |
| 5 |
PayPal
PYPL
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$292M |
| 2 |
FedEx
FDX
|
+$188M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$173M |
| 4 |
Monster Beverage
MNST
|
+$135M |
| 5 |
Target
TGT
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.45% |
| 2 | Financials | 14.27% |
| 3 | Consumer Discretionary | 14.13% |
| 4 | Healthcare | 11.46% |
| 5 | Industrials | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
ARS Pharmaceuticals
SPRY
$563M
| $110K | ﹤0.01% |
+20,117
| New | +$88.1K |
|
952
AXT Inc
AXTI
$2.8B
| $104K | ﹤0.01% |
+43,359
| New | +$96.9K |
|
953
KVH Industries
KVHI
$172M
| $99.4K | ﹤0.01% |
18,897
| – | – |
|
954
ThredUp
TDUP
$760M
| $97.1K | ﹤0.01% |
+43,135
| New | +$112K |
|
|
MAPS
955
DELISTED
WM TECHNOLOGY INC A
MAPS
| $97K | ﹤0.01% |
+134,731
| New | +$134K |
|
956
Blend Labs
BLND
$433M
| $96.9K | ﹤0.01% |
+37,984
| New | +$57.3K |
|
957
Accuray
ARAY
$29M
| $94.3K | ﹤0.01% |
33,330
-219,380
| -87% | -$599K |
|
958
SGHC Ltd
SGHC
$7.62B
| $89.9K | ﹤0.01% |
+28,362
| New | +$95.3K |
|
959
Verastem
VSTM
$547M
| $82.2K | ﹤0.01% |
10,103
| – | – |
|
|
EGRX
960
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $81.4K | ﹤0.01% |
15,568
+3,982
| +34% | +$39.3K |
|
|
BHIL
961
DELISTED
Benson Hill, Inc.
BHIL
| $79.8K | ﹤0.01% |
+13,123
| New | +$117K |
|
|
WHWK
962
Whitehawk Therapeutics
WHWK
$182M
| $62.4K | ﹤0.01% |
+30,877
| New | +$130K |
|
963
Absci
ABSI
$1.21B
| $59K | ﹤0.01% |
14,042
-399,637
| -97% | -$742K |
|
964
American Airlines Group
AAL
$10.2B
| – | – |
-62,779
| Closed | -$804K |
|
965
Adicet Bio
ACET
$76.7M
| – | – |
-20,850
| Closed | -$457K |
|
|
AKYA
966
DELISTED
Akoya BioSciences
AKYA
| – | – |
-55,801
| Closed | -$259K |
|
|
ALE
967
DELISTED
Allete
ALE
| – | – |
-14,158
| Closed | -$748K |
|
968
Alignment Healthcare
ALHC
$3.81B
| – | – |
-292,593
| Closed | -$2.03M |
|
969
Allegion
ALLE
$13.7B
| – | – |
-3,713
| Closed | -$387K |
|
970
ANI Pharmaceuticals
ANIP
$1.84B
| – | – |
-3,706
| Closed | -$215K |
|
971
Apple Hospitality REIT
APLE
$3.97B
| – | – |
-498,113
| Closed | -$7.64M |
|
972
AdvanSix
ASIX
$551M
| – | – |
-16,107
| Closed | -$501K |
|
973
Atlantic Union Bankshares
AUB
$6.11B
| – | – |
-21,910
| Closed | -$631K |
|
974
AZZ Inc
AZZ
$4.41B
| – | – |
-6,091
| Closed | -$278K |
|
975
Boeing
BA
$175B
| – | – |
-2,385
| Closed | -$457K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2023 Portfolio in Review
As of Q4 2023, Jacobs Levy Equity Management held 1,110 positions worth $19.8B, up 18% from $16.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jacobs Levy Equity Management deployed $774M of net new capital in Q4 2023, opening 158 new positions and adding to 343 existing holdings. Its largest new stake was lululemon athletica: 370,681 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $292M trimmed.
- Jacobs Levy Equity Management's largest Q4 2023 buy was lululemon athletica: 370,681 shares worth $190M.
- Jacobs Levy Equity Management added most to Old Dominion Freight Line in Q4 2023, an estimated $113M increase.
- Jacobs Levy Equity Management's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $292M.
- Jacobs Levy Equity Management fully exited Okta in Q4 2023, selling an estimated $57.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 23% of its $19.8B portfolio in Q4 2023.
- Jacobs Levy Equity Management opened 158 new positions and closed 147 in Q4 2023.
- Jacobs Levy Equity Management's portfolio value rose 18% quarter-over-quarter to $19.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2023, filed 14 Feb 2024.